Nowadays, obesity is one of the most prevalent human health problems. Research from the
last 30 years has clarified the role of the imbalance between energy intake and expenditure …

The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in
the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the …

The prevalence of obesity, diabetes, non-alcoholic fatty liver disease, and related metabolic
disorders has been steadily increasing in the past few decades. Apart from the …

Background and aims: gut microbiota (GM) is a complex ecosystem containing bacteria,
viruses, fungi, and yeasts. It has several functions in the human body ranging from …

Patients with chronic liver disease and cirrhosis demonstrate a global mucosal immune
impairment, which is associated with altered gut microbiota composition and functionality …

Chronic liver disease is reaching epidemic proportions with the increasing prevalence of
obesity, nonalcoholic liver disease, and alcohol overuse worldwide. Most patients are not …

Background Gut microbiota (GM) of patients with liver cancer is disordered, and syet no
study reported the GM distribution of liver cirrhosis‐induced HCC (LC‐HCC) and nonliver …

Background The mycobiome is the fungal component of the gut microbiome and is
implicated in several autoimmune diseases. However, its role in MS has not been studied …

The intestinal mucosa is constantly exposed to commensal microbes, opportunistic
pathogens, toxins, luminal components and other environmental stimuli. The intestinal …

With the recent availability and upgrading of many emerging intestinal microbes sequencing
technologies, our research on intestinal microbes is changing rapidly. A variety of …